THEME: "Experimental Challenges in Studies of Drug Discovery, Development and Lead Optimization"
As the need for more targeted drug therapies has increased and drug development has become more complex, the industry has seen a corresponding rise in the number of molecules with low solubility challenges. In light of this challenge, drug development experts must look to new technologies and methods to proactively address the challenges and ensure effective treatments are reaching patients in need.
The Drug Discovery, Development and Lead Optimization Webinar brings together experts in medicinal chemistry, structure-based drug design, computational chemistry, emerging drug targets, and novel technology platforms. The webinar is extremely interactive with enthusiastic question and answer sessions following each talk. This meeting remains unique with respect to the breadth of participants and focus on new approaches to discovering drugs. With large pharma reducing investment in internal early stage research, drug pipelines will increasingly be filled by alternative sources. These players include: government, academic labs, non-profits, biotech companies, and pharmaceutical “open innovation” models.
Over the course, internationally-renowned speakers will describe how their research journey has developed in response to contemporary challenges: inspirational and innovative lessons in drug research. The attending experts and industry partners will also provide a fantastic networking experience.
The Webinar will bring together scientists, researchers, entrepreneurs, academicians, medical officers, CEO’s, CSO’s and technologists from all over the world to debate on the latest scientific advances in the field of drug discovery & development that help to shape current and future challenges in drug research. We hope that you will take this opportunity to join us for academic exchange and B2B networking.
The meeting was extremely interactive with enthusiastic question and answer sessions following each talk (so much so it was hard to stay on time).This meeting remains unique with respect to the breadth of participants and focus on new approaches to discovering drugs.